Constitutive nitric oxide synthase (NOS), present in selective neurons, is regulated by intracellular cal cium (Bredt and Snyder, 1990; Bredt et aI., 1991). Ionotropic glutamate receptors, notably N-methyl-o aspartate (NMDA) receptors, have been shown to increase nitric oxide (NO) stimulated formation of cyclic GMP in vitro (Garthwaite et aI., 1989a,b; Sou tham et aI., 1991; Okada, 1992) .
Constitutive nitric oxide synthase (NOS), present in selective neurons, is regulated by intracellular cal cium (Bredt and Snyder, 1990; Bredt et aI., 1991) . Ionotropic glutamate receptors, notably N-methyl-o aspartate (NMDA) receptors, have been shown to increase nitric oxide (NO) stimulated formation of cyclic GMP in vitro (Garthwaite et aI., 1989a,b; Sou tham et aI., 1991; Okada, 1992) .
The role of metabotropic glutamate receptors (mGluRs) in regulating NOS activity has received less attention. This family of receptors are thought to be G-protein-linked to phospholipase C, adenyl cyclase, and, possibly, phospholipase D (Boss and Conn, 1992; Holler et aI., 1993; Schoepp and Conn, 1993; Winder and Conn, 1992) . Stimulation of phos pholipase C results in increased inositol triphosphate (IP3) formation and mobilization of intracellular cal cium stores, which, in cells containing NOS, could stimulate NO production. Application of the mGluR agonist trans-(1S,3R)-1-amino-1,3-cyclopentanedicar boxylic acid (ACPD) to cerebellar slices increases cyclic GMP (Okada, 1992) . Elevations in cyclic guanine monophosphate (GMP) in the extracellular fluid utilizing the technique of cerebral microdialysis have been demonstrated with local application of NMDA, 2-amino-3-hydroxy-5-methylisoxazole-4-pro pionic acid (AMPA), and ACPD in vivo (Luo et ai., 1994; Vallebuona and Raiteri, 1994) .
Direct measurements of NO in vivo is difficult due to the lability of the gas, although a porphyrinic mi crosensor has had limited use in the brain (Malinski et aI., 1993) . Formation of methemoglobin in micro dialysis effluent when kainate is administered system ically has been used as a marker of NO in vivo (Bilci oglu and Maher, 1993) . Catalytic activity of the en zyme in homogenized tissue is usually measured from the accumulation of radio labeled citrulline when the radiolabeled substrate L-arginine is added. We adapted this technique in vivo by perfusing microdia lysis probes with radiolabeled arginine, and measur ing radiolabeled citrulline in the dialysate effluent from both rat hippocampus (Bhardwaj et ai., 1995b) and lamb cortex (Northington et ai., 1995) . This mea sure is an indirect marker of NO production in vivo; nevertheless, we were able to show that addition of NMDA to the microdialysis perfusate increased ci trulline recovery, which was attenuated by adenosine Al receptor agonists and blocked by N-nitro-L-argi nine (LNNA) methyl ester, but not by its stereoiso mer. Therefore, the technique has adequate sensitiv ity for detecting NMDA-evoked increases in NO production as well as modulation of NO production by other drugs in vivo.
In the present study, we used ACPD (Palmer et ai., 1989; Schoepp et ai., 1991) to investigate the role of mGluRs in regulating NO production in vivo in rat hippocampus dialysed with labeled arginine. We tested the hypotheses that ACPD increases labeled citrulline recovery and that this increase is attenuated by the mGluR antagonist (± )-a-methyl-4-carboxy phenylglycine (MCPG) (Eaton et ai., 1993) but not by the NMDA receptor antagonist (+ )-5-methyl-1O,1l dihydro-5H-dibenzo [a, or by the non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX). We further tested the hypothesis that ACPD does not enhance citrulline recovery via neuronal activation secondary to epileptiform activity by perfusion with tetrodotoxin (TTX).
To our knowledge, no selective IP3 receptor ago nists presently exist. However, calcium-induced cal-cium release, mediated by intracellular ryanodine sensitive calcium channels shown to be present in brain (Sharp et aI., 1993) , may amplify NO produc tion. Dantrolene is an antagonist of ryanodine-sensi tive channels in muscle, and has been found to reduce intracellular calcium increases evoked by glutamate and NMDA (Bouchelouche et ai., 1989; Fransden and Schousboe, 1991; Simpson et ai., 1993) , as well as cytotoxicity from glutamate, NMDA and quisqualate (Fransden and Schousboe, 1992; Fransden and Schousboe, 1993) . Therefore, we also tested the hy pothesis that dantrolene reduces the ACPD-evoked increase in citrulline recovery in the dialysate.
MATERIALS AND METHODS
The experimental protocol was approved by the institu tional animal care and use committee of the Johns Hopkins University and conforms to National Institutes of Health guidelines for the care and use of animals in research.
Methods for surgical preparation, cerebral microdialysis, and measurement of [14C]-L-citrulline measurements have been described in detail in previous publications (Northing ton et aI., 1995; Bhardwaj et aI., 1995b) and will only be summarized here.
General surgical procedures
Adult male Sprague-Dawley rats (300-450 g) were anes thetized with intraperitoneal (i.p.) pentobarbital (60 mg/ kg). Rats were trachcotomized and mechanically ventilated to maintain normoxia and normocarbia. Arterial blood pressure, heart rate, and arterial blood gases were moni tored using tail artery cannulation throughout the course of the experiments. Rectal temperature was maintained at 37-38°C with a warming blanket. Care was taken to avoid direct heating of the animal's head, since this would alter the normal thermal gradients between the brain and the body core. Bilateral micro dialysis cannulae were placed into CA3 region of the hippocampus by stereotaxic surgery and fixed in position with dental cement. Animals were then removed from the stereotaxic apparatus and allowed a 60-min postsurgical equilibration period prior to beginning the experiment.
Microdialysis
Dialysis probes used in these studies were made with modifications (Northington et aI., 1995) according to the description of Johnson and Justice (1983) . Probes consisted of a single, hollow dialysis fiber, one end of which was sealed with epoxy. The dialysis membrane diameter was 300 JLm, and had a molecular mass cut-off of 5 kDa. Two hollow silica perfusion tubes were inserted into the dialysis fiber so that their ends were 5 mm apart. The distance between the tips comprised the effective dialyzing area of the cannula, as verified by perfusion with dye (Northington et aI., 1995; Bhardwaj et aI., 1995b) . After insertion, the' cannulae were perfused at a rate of 1 JLl/min. Estimation of NO production was performed using modi fications of the assay described previously by Bredt et al. (1990) . Arginine is converted to equimolar concentrations water, poured over a column, and washed as above. Radio activity of the flow-through was quantified by liquid scintil lation spectroscopy. Flow-through radioactivity of the non dialyzed CSF was assumed to be arginine, presuming that no conversion of arginine to citrulline occurred in thc CSF not exposed to any source of enzyme activity. Specific activ ity was corrected for counting efficiency and background activity, and expressed as femtomoles/min of perfusion. As an internal control, 100 ILl of CSF not used for dialysis and not exposed to resin was directly assayed for activity to ensure that consistent concentrations of [14C]-L-arginine were added to the CSF. Aliquots of CSF containing known amounts of radio labeled arginine and citrulline were poured over columns to determine trapping and flow through efficiency. The efficiency of arginine trapping was >99% and that of citrulline flow-through was >86%. The detection limit was 16 femtomoles/min. Experimental groups were as follows: group 1, control CSF versus 1 mM ACPD (n = 8); group 2, 1 mM ACPD versus 1 mM ACPD + 1 mM LNNA (n = 7); group 3, 1 mM ACPD versus 1 mM ACPD + 1 mM MCPG (n = 8); group 4, 1 mM ACPD versus 1 mM ACPD + 1 mM dantrolene (n = 8); group 5, control CSF versus 1 mM MCPG (n = 7); group 6, control CSF versus I mM dantrolene (n = 8); group 7, 1 mM ACPD versus 1 mM ACPD + 1 mM MK-801 (n = 8); group 8, 1 mM ACPD versus 1 mM ACPD + 1 mM CNQX (n = 7); and group 9, 1 mM ACPD versus 1 mM ACPD + 1 mM TTX (n = 5).
Experimental groups
In preliminary experiments using a similar experimental paradigm, we found that a I-mM concentration of MK-801 and CNQX attenuates the NMDA and 2-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)-enhanced ci trulline recovery (Bhardwaj et ai., 1994 (Bhardwaj et ai., , 1995a . The 1-mM concentration of ACPD that we used in the infusate is relatively high. However, citrulline recovery with these micro dialysis probes is <10% (Bhardwaj et ai., 1995b) , and the concentration of ACPD immediately outside the dialysis membrane is probably <10% that of the infusate. 
Statistical analysis
Within each group, effluent citrulline data were analyzed by two-way analysis of variance (ANOY A) where the two treatments delivered to the two hippocampi was one within-subject factor, and the five hourly collections were a second within-subject factor. If the overall effect of treat ment or the treatment X time interaction was significant, comparisons of mean values between the two treatments at individual time points were made by Newman-Keuls multiple range test; p < 0.05 was considered significant.
Within each group, time-dependent changes in hemody namic and blood gas data were determined with one-way repeated measures ANOYA. Data are presented as means ± SD.
RESULTS
In group 1, perfusion with [14C]-L-arginine in arti ficial CSF resulted in increases in [14C]-L-citrulline in the effluent. The nature of these time-dependent increases represent the time required for diffusion of labeled arginine into the tissue and the time required for diffusion of labeled citrulline back into the probe. In the side perfused with 1 mM ACPD, recovery of labeled citrulline was increased from the third through the fifth hour of perfusion compared to the control side (Fig. lA) . In group 2, combined perfu sion of 1 mM ACPD + 1 mM LNNA reduced labeled citrulline recovery from the third to the fifth hour compared to perfusion with 1 mM ACPD alone (Fig. IB) .
In group 3, combined perfusion of 1 mM ACPD + 1 mM MCPG attenuated labeled citrulline recovery from the third to the fifth hour compared to 1 mM ACPD alone ( Fig. 2A) . In group 4, combined perfu sion of 1 mM ACPD + 1 mM dantrolene attenuated labeled citrulline recovery from the third to the fifth hour compared to perfusion with 1 mM ACPD alone (Fig.2B) .
In group 5, perfusion of 1 mM MCPG did not change labeled citrulline recovery as compared to control CSF alone (Fig. 3A) . In group 6, perfusion of 1 mM dantrolene did not change labeled citrulline recovery compared to control CSF alone ( Fig. 38) . In group 7, combined perfusion of 1 mM ACPD + 1 mM MK-801 did not change labeled citrulline re covery as compared to perfusion with 1 mM ACPD alone throughout the course of the experiment ( Fig.   4A ). In group 8, combined perfusion of 1 mM ACPD + 1 mM CNQX did not change labeled citrulline recov ery as compared to perfusion with 1 mM ACPD alone throughout the course of the experiment (Fig. 4B) . In group 9, combined perfusion of 1 mM ACPD + 1 mM TTX did not change labeled citrulline recovery as compared to perfusion with 1 mM ACPD alone throughout the course of the experiment (Fig. 5) .
Mean arterial pressure, arterial blood gases, pH, and rectal temperatures were stable throughout the experiment. Values obtained during the fifth hour of perfusion are summarized in Table 1 .
DISCUSSION
The significant finding of this study is that local administration of the mGluR agonist ACPD en hances NO production in the hippocampus in vivo as measured indirectly by conversion of arginine to citrulline. This ACPD-enhanced NO production was attenuated by the mGluR antagonist MCPG but not by MK-801 or CNQX, indicating that the action of ACPD was mediated by mGluR rather than by down stream activation of NMDA or AMP A receptors. Furthermore, the ACPD-evoked increase in citrul line recovery was inhibited by dantrolene, which sug gests that calcium-induced calcium release mediated by intracellular ryanodine-sensitive channels plays a role in amplifying the mGluR response. The tip of the dialysis probes were localized in the CA3 region of the hippocampus, as confirmed by postmortem infusion of methylene blue dye. Neurons containing NOS have been identified in the hippo campus (Bredt et aI., 1991; Valtschanoff et aI., 1993) . We have further confirmed the presence of these neurons immunohistochemically with an antibody to the neuronal isoform of NOS in the pyramidal area of the CA3 hippocampal region (Bhardwaj et aI, 1995b; Duneral, 1994) . In addition, the endothelial isoform of NOS appears to be present in hippocampal pyramidal neurons (Dinerman et aI., 1994) ; thus, the necessary NO synthetic mechanisms are present. In addition, cellular localization of phosphoinositide linked mGluR has been demonstrated in the rat hip pocampus using antibodies that recognize the C terminus of the mGluR (Martin et aI., 1992) .
The present results extend our previous studies with NMDA (Bhardwaj et aI., 1994 (Bhardwaj et aI., , 1995a Northington et aI., 1995) and indicate that glutamate may regulate NO production in vivo not only via NMDA receptors but also via mGluRs. ACPD may stimulate presynaptic adenyl cyclase-coupled mGluR (Adam son et aI., 1990) to facilitate release of glutamate, which could act postsynaptically by stimulating NMDA and nonNMDA receptors on NOS neurons. However, this mechanism seems less likely since MK-801 and CNQX failed to inhibit ACPD-evoked in creases in citrulline recovery. Stimulation of AMPA receptors has been reported to inhibit ACPD-evoked increases in inositol triphosphate, and the inhibition was reversed by CNQX (Lonart et aI., 1993) . We did not find that CNQX augmented ACPD-evoked citrulline release, suggesting that any tonic effect of AMP A receptor stimulation was too low to inhibit an effect of ACPD on NO production. Therefore, the ACPD-stimulated NO production appears to be a response mediated directly by postsynaptic mGluRs. The simplest model to explain these results is that phosphoinositide-coupled mGluR on NOS containing neurons are directly stimulated by ACPD, resulting in inositol triphosphate receptor-mediated mobilization of intracellular calcium, with further cal cium amplification by ryanodine receptors sufficient to stimulate NOS. This interpretation is supported by observations showing that non pyramidal neu rons in CA sub fields postsynaptically express the phosphoinositide-linked mGluR1 a (Martin et aI., 1992) and that subsets of these neurons are NOS positive (Dun et aI., 1994) . Alternatively, the phosphoinositide-linked mGluR5 is the dominant mGluR subtype in the hippocampus (Abe et aI., 1992) . Activation of this receptor on pyramidal neu rons may lead to feed-forward activation (Lacaille et O':=.
. ai., 1987) of nonpyramidal neurons, some of which are likely to be NOS-positive. Further support for these observations is derived from immunocytochemical studies showing that inositol triphosphate receptor and ryanodine-sensitive calcium channels are present in the hippocampus (Sharp et ai., 1993) . However, spatial het erogeneity between these two intracellular calcium channels exists in cell bodies, axons, and dendrites. Thus, regulation of NOS activity by calcium may be dependent upon the loci within the cell, and this spatial regulation may differ in different brain regions.
Another possibility is that ACPD may act via multisymiptic pathways rather than directly on NOS neurons. For example, ACPD activation of mGluR5 on CA3 pyramidal neurons may facilitate hippocam pal-septal and septal-hippocampal pathways (Zheng and Gallagher, 1992) , which could then evoke the release of acetylcholine in the hippocampus. Lack of inhibition by MK-801 and CNQX argues against a multisynaptic pathway. Moreover, ACPD augments long-term depression and decreases excitatory post synaptic currents in hippocampal slices (Bolshakov and Siegelbaum, 1994) , thereby decreasing efficiency of neurotransmission in specific pathways. However, other reports show that a long-lasting enhancement of synaptic excitability is produced by activation of mGluRs (Liu et ai., 1993) . Local perfusion with TTX failed to attenuate ACPD-enhanced citrulline recov ery, thereby further suggesting that the effect of ACPD is not via neuronal activation caused by epi leptiform activity. Although the interstitial concen tration of TTX may be an order of magnitude less than the microdialysis perfusate concentration of 1 mmollL, the local interstitial concentration should be adequate to inhibit epileptiform activity, since only micromolar concentrations of TTX are sufficient for blocking Na+ channels (Katz and Miledi, 1967) .
In the absence of ACPD, MCPG and dantrolene did not decrease citrulline recovery below basal lev els. These results suggest that any tonic effect of mGluR activity on NO production is relatively smali.
The lack of a significant decrease below basal levels is unlikely to be due to an inability of the technique to detect significant decreases, since we have previously detected decreases in citrulline recovery below basal levels using 2-chloroadenosine or nitroarginine methyl ester administration (Bhardwaj et ai., 1995b; Northington et ai., 1995) . Alternatively, use of pento barbital anesthesia may have suppressed tonic mGluR activity in the present study.
Cerebral microdialysis measures neurochemical changes occurring in the brain extracellular fluid, a microenvironment that serves as a communication between neurons, glia, and the vasculature. [14C)-L citrulline recovery increased over time in controls. This is attributable to (a) diffusion of [14C)-L-arginine away from the dialysis probe over time and recruit ment of distant cells capable of producing NO, and (b) time-dependent extrusion of radiolabeled citrul line from the cell, and diffusion back to and across the dialysis membrane. Others have shown increases in cyclic GMP in microdialysis effluent from rat cere bellum within 20 min of adding ACPD to the perfu sate (Luo et ai., 1994) and in effluent from rat hippo campus within 20 min after adding NMDA to the perfusate (Vailebuona and Raiteri, 1994, 1995) . Therefore, a disadvantage of our technique is poor temporal resolution.
Also, a significant fraction of labeled citrulline may be recycled back to arginine, leading to an underesti mation of NO production. We assume that this frac tion remains relatively constant with ACPD adminis tration. Inhibition of the response with LNNA is used to infer that increased citrulline recovery is mediated by increased NOS activity. However, we cannot ex clude that LNNA might also inhibit [14C)-L-arginine uptake (Westergaard et ai., 1993) . There was also interanimal variability, which we attempted to mini mize by using a paired experimental design between the two hippocampi. All drugs were administered locally to reduce the likelihood of systemic or trans callosal interactions. As with all studies using micro-dialysis, one has to consider the effect of local trauma and consequent astrocytosis. The immunologic NOS (iNOS) isoform can be induced in astrocytes (Endoh et aI., 1994; Simmons and Murphy, 1992) , and subsets of astrocytes express adenyl cyclase-coupled mOluR (Ohishi et aI., 1993) . However, we detected significant increases with ACPD by the 2-3-h collection period (3-4 h after probe insertion), and we consider it un likely that substantial amounts of iNOS are expressed by this time. Moreover, activation of iNOS is calcium independent and we would not expect the response to be blocked with dantrolene, as in this case.
In conclusion, this study demonstrates that mOluR stimulation enhances NO production in the hippo campus as measured in vivo by labeled citrulline recovery following labeled arginine infusion. Inhibi tion of the response with dantrolene suggests that ryanodine-sensitive calcium channels sufficiently am plify the inositol triphosphate-induced calcium tran sients to increase calcium-dependent NOS activity. Therefore, mOluRs as well as ionotropic glutamate receptors need to be considered in the regulation of NO production in vivo. 
